N
BSX icon

Natixis’s Boston Scientific BSX Stock Holding History

Natixis’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-63,900
Closed -$2.96M – 1004
2022
Q4 		$2.96M Buy
+63,900
New +$2.77M 0.02% 472

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Natixis's BSX Position: Q2 2026 in Review

Natixis reduced its Boston Scientific (BSX) stake by 69% in Q2 2026, selling an estimated $20.2M and leaving 168,036 shares worth $7.17M. The position accounts for 0.03% of the portfolio, ranked #365.

Natixis first reported a position in BSX in Q2 2013 and has held it in 46 quarters since. The position peaked at $74.7M in Q4 2021. 1,477 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Natixis held 168,036 shares of Boston Scientific worth $7.17M as of Q2 2026.
  • Natixis sold 372,027 Boston Scientific shares in Q2 2026, an estimated $20.2M.
  • Boston Scientific made up 0.03% of Natixis's portfolio in Q2 2026, its #365 holding.
  • Natixis first reported a position in Boston Scientific in Q2 2013 and has held it in 46 quarters since.
  • Natixis's Boston Scientific position peaked at $74.7M in Q4 2021.
  • 1,477 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.